Login / Signup
Paul Okediji
ORCID
Publication Activity (10 Years)
Years Active: 2020-2022
Publications (10 Years): 2
Top Topics
Alcohol Use Disorder
Respiratory Syndrome Coronavirus
Nitric Oxide Synthase
Low Dose
Top Venues
Pharmacological reports : PR
Pain management
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Samuel J Martin
,
Heath B McAnally
,
Paul Okediji
,
Moshe Rogosnitzky
Low-dose naltrexone, an opioid-receptor antagonist, is a broad-spectrum analgesic: a retrospective cohort study.
Pain management
12 (6) (2022)
Moshe Rogosnitzky
,
Paul Okediji
,
Igor Koman
Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19.
Pharmacological reports : PR
72 (6) (2020)